New study tests second round of gene therapy for rare throat condition
NCT ID NCT06538480
Summary
This study is testing a second course of an experimental gene therapy called zopapogene imadenovec for adults with recurrent respiratory papillomatosis (RRP), a rare condition causing wart-like growths in the throat. Researchers want to see if a repeat treatment is safe and effective at preventing the need for future surgical procedures to remove these growths. They are also tracking how the body processes and eliminates the therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT RESPIRATORY PAPILLOMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institute of Health
RECRUITINGBethesda, Maryland, 20892, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45267, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Winship Cancer Institute, Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.